103 related articles for article (PubMed ID: 1412603)
1. Subjective side effects of mianserin in relation to plasma concentrations of mianserin and desmethylmianserin.
Otani K; Sasa H; Higuchi H; Kaneko S; Hishikawa Y; Fukushima Y
Ther Drug Monit; 1992 Jun; 14(3):190-3. PubMed ID: 1412603
[TBL] [Abstract][Full Text] [Related]
2. Steady-state plasma concentrations of mianserin and its major active metabolite, desmethylmianserin.
Otani K; Sasa H; Kaneko S; Kondo T; Fukushima Y
Ther Drug Monit; 1993 Apr; 15(2):113-7. PubMed ID: 8503138
[TBL] [Abstract][Full Text] [Related]
3. Effects of thioridazine, an inhibitor of CYP2D6, on the steady-state plasma concentrations of the enantiomers of mianserin and its active metabolite, desmethylmianserin, in depressed Japanese patients.
Yasui N; Tybring G; Otani K; Mihara K; Suzuki A; Svensson JO; Kaneko S
Pharmacogenetics; 1997 Oct; 7(5):369-74. PubMed ID: 9352572
[TBL] [Abstract][Full Text] [Related]
4. Prediction of plasma concentrations of mianserin and desmethylmianserin at steady state from those after an initial dose of mianserin.
Otani K; Mihara K; Okada M; Tanaka O; Kaneko S; Fukushima Y
Ther Drug Monit; 1993 Apr; 15(2):118-21. PubMed ID: 8503139
[TBL] [Abstract][Full Text] [Related]
5. Enantioselective determination of mianserin and its desmethyl metabolite in plasma during treatment of depressed Japanese patients.
Tybring G; Otani K; Kaneko S; Mihara K; Fukushima Y; Bertilsson L
Ther Drug Monit; 1995 Oct; 17(5):516-21. PubMed ID: 8585116
[TBL] [Abstract][Full Text] [Related]
6. Determination of the enantiomers of mianserin, desmethylmianserin, and 8-hydroxymianserin in the plasma and urine of mianserin-treated patients.
Eap CB; Powell K; Campus-Souche D; Monney C; Baettig D; Taeschner W; Baumann P
Chirality; 1994; 6(7):555-63. PubMed ID: 7986669
[TBL] [Abstract][Full Text] [Related]
7. Blood levels of mianserin and amitriptyline and clinical response in aged depressed patients.
Monteleone P; Fabrazzo M
Pharmacopsychiatry; 1994 Nov; 27(6):238-41. PubMed ID: 7870745
[TBL] [Abstract][Full Text] [Related]
8. Plasma concentrations of mianserin after single dose and at steady-state in depressed elderly patients.
Dawling S; Ford S; Ariyanayagam P; O'Neal H; Lewis RR
Clin Pharmacokinet; 1987 Jan; 12(1):73-8. PubMed ID: 3816006
[TBL] [Abstract][Full Text] [Related]
9. Long-term treatment with mianserin: a clinical study with plasma levels.
Altamura AC; Bareggi SR; Cornaggia CM; Grieco G; Invernizzi G; Melorio T; Zecca L
Adv Biochem Psychopharmacol; 1982; 32():357-61. PubMed ID: 7090900
[No Abstract] [Full Text] [Related]
10. Relationship between mirtazapine dose, plasma concentration, response, and side effects in clinical practice.
Grasmäder K; Verwohlt PL; Kühn KU; Frahnert C; Hiemke C; Dragicevic A; von Widdern O; Zobel A; Maier W; Rao ML
Pharmacopsychiatry; 2005 May; 38(3):113-7. PubMed ID: 15902580
[TBL] [Abstract][Full Text] [Related]
11. Analytical method development and validation of mianserin hydrochloride and its metabolite in human plasma by LC-MS.
Chauhan B; Rani S; Guttikar S; Zope A; Jadon N; Padh H
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 823(2):69-74. PubMed ID: 16006201
[TBL] [Abstract][Full Text] [Related]
12. Clinical effects of mianserin in endogenous depression and their relationship to drug plasma level.
Oyewumi LK; Lapierre YD; Hrdina PD
Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):733-8. PubMed ID: 6686702
[TBL] [Abstract][Full Text] [Related]
13. A controlled study of the efficacy and safety of mianserin and amitriptyline in depressive inpatients.
Möller HJ; Kasper S; Müller H; Kissling W; Fuger J; Ruhrmann S
Pharmacopsychiatry; 1995 Nov; 28(6):249-52. PubMed ID: 8773291
[TBL] [Abstract][Full Text] [Related]
14. A double blind comparative study of mianserin and a fixed combination of amitriptyline plus chlordiazepoxide.
Dimitriou EC; Logothetis JA; Paschalidou M
Adv Biochem Psychopharmacol; 1982; 32():213-22. PubMed ID: 7046365
[TBL] [Abstract][Full Text] [Related]
15. A double-blind trial of mianserin and nomifensine in depressed outpatients.
Hamouz W; Van Dorth R; Pinder RM; Stulemeijer SM
Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):219S-225S. PubMed ID: 6337609
[TBL] [Abstract][Full Text] [Related]
16. The CYP2D6 genotype and plasma concentrations of mianserin enantiomers in relation to therapeutic response to mianserin in depressed Japanese patients.
Mihara K; Otani K; Tybring G; Dahl ML; Bertilsson L; Kaneko S
J Clin Psychopharmacol; 1997 Dec; 17(6):467-71. PubMed ID: 9408809
[TBL] [Abstract][Full Text] [Related]
17. Treatment of childhood and adolescent depression with mianserin.
Dugas M; Mouren MC; Halfon O; Moron P
Acta Psychiatr Scand Suppl; 1985; 320():48-53. PubMed ID: 3863468
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of controlled studies comparing mianserin and clomipramine (author's transl)].
de Buck RP
Encephale; 1981; 7(4 Suppl):455-72. PubMed ID: 7032887
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological aspects of mianserin.
Pinder RM; van Delft AM
Acta Psychiatr Scand Suppl; 1983; 302():59-71. PubMed ID: 6301219
[TBL] [Abstract][Full Text] [Related]
20. [An open study of Mianserin (author's transl)].
Lemperiere T; Feline A; Ades J; Ferrand I
Encephale; 1981; 7(4 Suppl):445-54. PubMed ID: 7318760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
